Kiniksa Pharmaceuticals International, plc (KNSA) › EPS (Diluted)Kiniksa Pharmaceuticals International, plc (KNSA) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2019: $-2.992020: $-2.612021: $-2.302022: $2.602023: $0.202024: $-0.602025: $0.75$0.752019EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$0.75+225.0%2024$-0.60-400.0%2023$0.20-92.3%2022$2.60+213.0%2021$-2.30+11.9%2020$-2.61+12.7%2019$-2.99—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share